BIOLOGICAL EFFECT OF ORALLY ACTIVE PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST SM-10661

被引：0
|
作者：
KOMURO, Y [1 ]
IMANISHI, N [1 ]
UCHIDA, M [1 ]
MOROOKA, S [1 ]
机构：
[1] SUMITOMO PHARMACEUT CO LTD,RES LABS,1-98 KASUGADE NAKA 3 CHOME,KONAHANA KU,OSAKA 554,JAPAN
来源：
MOLECULAR PHARMACOLOGY | 1990年 / 38卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：378 / 384
页数：7
相关论文
共 50 条
  • [31] EFFECT OF PLATELET-ACTIVATING FACTOR AND ITS RECEPTOR ANTAGONIST, SRI-63-675, ON GASTRIC BLEEDING IN RATS
    BERSTAD, A
    ALMODOVAR, K
    WEATHERSTONE, RG
    HIRSCHOWITZ, BI
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 (06) : 738 - 742
  • [32] DIRECT ENANTIOMERIC SEPARATION OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST SM-10661 BY LIGAND-EXCHANGE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH A COPPER(II) N,S-DIOCTYL-D-PENICILLAMINE COMPLEX
    OKAMOTO, M
    UEDA, Y
    TAKAHASHI, K
    NAKAZAWA, H
    DOI, T
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1995, 59 (09) : 1740 - 1741
  • [33] PLATELET-ACTIVATING FACTOR ANTAGONIST PROTECTIVE IN FOCAL BRAIN INJURY
    FRERICHS, KU
    LINDSBERG, PJ
    HALLENBECK, JM
    FEUERSTEIN, GZ
    STROKE, 1990, 21 (01) : 180 - 180
  • [34] Inhibitory effect of pranlukast, a cysteinyl leukotriene receptor-antagonist, on eosinophil activation induced by platelet-activating factor
    Suzuki, M
    Kato, M
    Kimura, H
    Tachibana, A
    Fujiu, T
    Arakawa, H
    Mochizuki, H
    Tokuyama, K
    Morikawa, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S225 - S225
  • [35] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
  • [36] DISCOVERY OF A-85783, A POTENT, ORALLY-ACTIVE ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    HOLMS, JH
    DAVIDSEN, SK
    SHEPPARD, GS
    CURTIN, ML
    CARRERA, GM
    HEYMAN, HR
    PIREH, D
    ALBERT, DH
    CONWAY, RG
    MAGOC, TJ
    RHEIN, DA
    TAPANG, P
    SUMMERS, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 176 - MEDI
  • [37] Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor
    Wang, H
    Tan, XD
    Chang, H
    GonzalezCrussi, F
    Remick, DG
    Hsueh, W
    BIOCHEMICAL JOURNAL, 1997, 322 : 603 - 608
  • [38] A NOVEL PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST
    WINSLOW, CM
    VALLESPIR, SR
    FRISCH, GE
    DARIES, FJ
    DELILLO, AK
    HOULIHAN, WJ
    PARRINO, V
    SCHMITT, G
    SAUNDERS, RN
    PROSTAGLANDINS, 1985, 30 (04): : 697 - 697
  • [39] Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor- deficient mice with age
    Sugatani, Junko
    Sadamitsu, Satoshi
    Yamaguchi, Masahiko
    Yamazaki, Yasuhiro
    Higa, Ryoko
    Hattori, Yoshiki
    Uchida, Takahiro
    Ikari, Akira
    Sugiyama, Wataru
    Watanabe, Tatsuo
    Ishii, Satoshi
    Miwa, Masao
    Shimizu, Takao
    FASEB JOURNAL, 2014, 28 (01): : 440 - 452
  • [40] PLATELET-ACTIVATING FACTOR - A BIOLOGICALLY-ACTIVE PHOSPHOLIPID
    OSTERMANN, G
    KERTSCHER, HP
    HOFMANN, B
    PHARMAZIE, 1990, 45 (07): : 465 - 487
12345